{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T17:57:23Z","timestamp":1793901443531,"version":"4.8.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,17]],"date-time":"2022-10-17T00:00:00Z","timestamp":1665964800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,17]],"date-time":"2022-10-17T00:00:00Z","timestamp":1665964800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology","doi-asserted-by":"publisher","award":["DST\/ICPS\/EDA\/2018"],"award-info":[{"award-number":["DST\/ICPS\/EDA\/2018"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology , Ministry of Science and Technology","doi-asserted-by":"publisher","award":["Core grant received from the Department of Biotechnology"],"award-info":[{"award-number":["Core grant received from the Department of Biotechnology"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology , Ministry of Science and Technology","doi-asserted-by":"publisher","award":["Government of India to National Institute of Immunology"],"award-info":[{"award-number":["Government of India to National Institute of Immunology"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Retinitis pigmentosa (RP) is a hereditary retinal disease which leads to visual impairment. The onset and progression of RP has physiological consequences that affects the ocular environment.\u00a0Some of the key non-genetic factors which hasten the retinal degeneration in RP include oxidative stress, hypoxia and ocular inflammation. In this study, we investigated the status of the ocular immune privilege during retinal degeneration and the effect of ocular immune changes on the peripheral immune system in RP. We assessed the peripheral blood mononuclear cell stimulation by retinal antigens and their immune response status in RP patients. Subsequently, we examined alterations in ocular immune privilege machineries which may contribute to ocular inflammation and disease progression in rd1 mouse model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In RP patients, we observed a suppressed anti-inflammatory response to self-retinal antigens, thereby indicating a deviated response to self-antigens. The\u00a0ocular milieu\u00a0in rd1 mouse model indicated a significant decrease in immune suppressive ligands and cytokine TGF-B1, and higher pro-inflammatory ocular protein levels.\u00a0Further, blood\u2013retinal-barrier breakdown due to decrease in the expression of tight junction proteins was observed. The retinal breach potentiated pro-inflammatory peripheral immune activation\u00a0against retinal antigens\u00a0and caused infiltration of the\u00a0peripheral immune cells into the ocular tissue.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our studies with RP patients and rd1 mouse model suggest that immunological consequences in RP is a contributing factor in the progression of retinal degeneration. The ocular inflammation in the RP alters the ocular immune privilege mechanisms and peripheral immune response. These aberrations in turn create an auto-reactive immune environment and accelerate retinal degeneration.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-022-02528-x","type":"journal-article","created":{"date-parts":[[2022,10,17]],"date-time":"2022-10-17T06:02:45Z","timestamp":1665986565000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Immunological consequences of compromised ocular immune privilege accelerate retinal degeneration in retinitis pigmentosa"],"prefix":"10.1186","volume":"17","author":[{"given":"K. Varsha","family":"Mohan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaknanda","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abaranjitha","family":"Muniyasamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prakriti","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parul","family":"Sahu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashwani","family":"Kesarwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kshama","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Perumal","family":"Nagarajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinod","family":"Scaria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manisha","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naseem S.","family":"Akhter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chanda","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5560-822X","authenticated-orcid":false,"given":"Pramod","family":"Upadhyay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,17]]},"reference":[{"issue":"3","key":"2528_CR1","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/S0161-6420(97)30291-7","volume":"104","author":"S Grover","year":"1997","unstructured":"Grover S, Fishman GA, Anderson RJ, Alexander KR, Derlacki DJ. Rate of visual field loss in retinitis pigmentosa. Ophthalmology. 1997;104(3):460\u20135.","journal-title":"Ophthalmology"},{"key":"2528_CR2","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/1750-1172-1-40","volume":"1","author":"C Hamel","year":"2006","unstructured":"Hamel C. Retinitis pigmentosa. Orphanet J Rare Dis. 2006;1:40.","journal-title":"Orphanet J Rare Dis"},{"issue":"9549","key":"2528_CR3","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1016\/S0140-6736(06)69740-7","volume":"368","author":"DT Hartong","year":"2006","unstructured":"Hartong DT, Berson EL, Dryja TP. Retinitis pigmentosa. The Lancet. 2006;368(9549):1795\u2013809.","journal-title":"The Lancet"},{"issue":"6","key":"2528_CR4","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1006\/mthe.2001.0498","volume":"4","author":"LH McGee Sanftner","year":"2001","unstructured":"McGee Sanftner LH, Abel H, Hauswirth WW, Flannery JG. Glial cell line derived neurotrophic factor delays photoreceptor degeneration in a transgenic rat model of retinitis pigmentosa. Mol Ther. 2001;4(6):622\u20139.","journal-title":"Mol Ther"},{"issue":"1","key":"2528_CR5","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.ophtha.2012.07.006","volume":"120","author":"N Yoshida","year":"2013","unstructured":"Yoshida N, Ikeda Y, Notomi S, Ishikawa K, Murakami Y, Hisatomi T, et al. Laboratory evidence of sustained chronic inflammatory reaction in retinitis pigmentosa. Ophthalmology. 2013;120(1):100\u20135.","journal-title":"Ophthalmology"},{"issue":"1","key":"2528_CR6","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.ophtha.2012.07.006","volume":"120","author":"N Yoshida","year":"2013","unstructured":"Yoshida N, Ikeda Y, Notomi S, Ishikawa K, Murakami Y, Hisatomi T, et al. Clinical evidence of sustained chronic inflammatory reaction in retinitis pigmentosa. Ophthalmology. 2013;120(1):100\u20135.","journal-title":"Ophthalmology."},{"issue":"15","key":"2528_CR7","first-page":"658","volume":"54","author":"N Yoshida","year":"2013","unstructured":"Yoshida N, Ikeda Y, Notomi S, Ishikawa K, Murakami Y, Hisatomi T, et al. Relation between sustained chronic inflammatory reaction and oxidative damage in an animal model of retinitis pigmentosa. Investig Ophthalmol Visu Sci. 2013;54(15):658.","journal-title":"Investig Ophthalmol Visu Sci"},{"issue":"6","key":"2528_CR8","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.it.2015.04.003","volume":"36","author":"VL Perez","year":"2015","unstructured":"Perez VL, Caspi RR. Immune mechanisms in inflammatory and degenerative eye disease. Trends Immunol. 2015;36(6):354\u201363.","journal-title":"Trends Immunol"},{"key":"2528_CR9","first-page":"724648","volume":"2013","author":"SM Whitcup","year":"2013","unstructured":"Whitcup SM, Nussenblatt RB, Lightman SL, Hollander DA. Inflammation in retinal disease. Int J Inflam. 2013;2013:724648.","journal-title":"Int J Inflam"},{"issue":"11","key":"2528_CR10","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1167\/iovs.61.11.30","volume":"61","author":"A Okita","year":"2020","unstructured":"Okita A, Murakami Y, Shimokawa S, Funatsu J, Fujiwara K, Nakatake S, et al. Changes of serum inflammatory molecules and their relationships with visual function in retinitis pigmentosa. Investig Ophthalmol Visu Sci. 2020;61(11):30.","journal-title":"Investig Ophthalmol Visu Sci"},{"issue":"9","key":"2528_CR11","first-page":"838","volume":"15","author":"M Kumar","year":"1983","unstructured":"Kumar M, Gupta RM, Nema HV. Role of autoimmunity in retinitis pigmentosa. Ann Ophthalmol. 1983;15(9):838\u201340.","journal-title":"Ann Ophthalmol"},{"key":"2528_CR12","volume-title":"Increased protein citrullination as a\u00a0trigger for resident immune system activation, intraretinal inflammation, and promotion of anti-retinal autoimmunity: intersecting paths in retinal degenerations of potential therapeutic relevance","year":"2019","unstructured":"Iannaccone A, Radic MZ, editors. Increased protein citrullination as a\u00a0trigger for resident immune system activation, intraretinal inflammation, and promotion of anti-retinal autoimmunity: intersecting paths in retinal degenerations of potential therapeutic relevance. Cham: Springer; 2019."},{"issue":"10","key":"2528_CR13","doi-asserted-by":"publisher","first-page":"4264","DOI":"10.1167\/iovs.16-19859","volume":"57","author":"D Tonade","year":"2016","unstructured":"Tonade D, Liu H, Kern TS. Photoreceptor cells produce inflammatory mediators that contribute to endothelial cell death in diabetes. Invest Ophthalmol Vis Sci. 2016;57(10):4264\u201371.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5","key":"2528_CR14","doi-asserted-by":"publisher","first-page":"2727","DOI":"10.4049\/jimmunol.169.5.2727","volume":"169","author":"MS Gregory","year":"2002","unstructured":"Gregory MS, Repp AC, Holhbaum AM, Saff RR, Marshak-Rothstein A, Ksander BR. Membrane Fas ligand activates innate immunity and terminates ocular immune privilege. J Immunol. 2002;169(5):2727\u201335.","journal-title":"J Immunol"},{"key":"2528_CR15","doi-asserted-by":"publisher","first-page":"765","DOI":"10.3389\/fimmu.2018.00765","volume":"9","author":"G Adamus","year":"2018","unstructured":"Adamus G. Are anti-retinal autoantibodies a cause or a consequence of retinal degeneration in autoimmune retinopathies? Front Immunol. 2018;9:765.","journal-title":"Front. Immunol."},{"issue":"8","key":"2528_CR16","first-page":"3234","volume":"62","author":"O Alekseev","year":"2021","unstructured":"Alekseev O, Adamus G, Iannaccone A. Inflammatory findings in autosomal recessive retinitis pigmentosa (ARRP) associated with EYS gene mutations. Investig Ophthalmol Vis Sci. 2021;62(8):3234.","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"7","key":"2528_CR17","first-page":"169","volume":"56","author":"R Epstein","year":"2015","unstructured":"Epstein R, New D, Hollingsworth T, Meunier I, Lenchik N, Lu Q, et al. Defective mer-tyrosine kinase (mer-TK) function is associated with anti-arrestin and anti-interphotoreceptor retinoid-binding protein (IRBP) autoantibodies (AAbs) in Mer, Axl, Tyro3\u2212\/\u2212 (TAM) mice and in autosomal recessive retinitis pigmentosa (arRP) patients with a null MERTK mutation. Investig Ophthalmol Vis Sci. 2015;56(7):169.","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"8","key":"2528_CR18","doi-asserted-by":"publisher","first-page":"3499","DOI":"10.1167\/iovs.07-1168","volume":"49","author":"D Salom","year":"2008","unstructured":"Salom D, Diaz-Llopis M, Garc\u00eda-Delpech S, Udaondo P, Sancho-Tello M, Romero FJ. Aqueous humor levels of vascular endothelial growth factor in retinitis pigmentosa. Invest Ophthalmol Vis Sci. 2008;49(8):3499\u2013502.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10","key":"2528_CR19","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1038\/eye.2008.382","volume":"23","author":"AW Taylor","year":"2009","unstructured":"Taylor AW. Ocular immune privilege. Eye (Lond). 2009;23(10):1885\u20139.","journal-title":"Eye (Lond)"},{"issue":"2","key":"2528_CR20","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3109\/08820538709062512","volume":"2","author":"JV Forrester","year":"1987","unstructured":"Forrester JV, Reid DM, Campbell AM. Autoimmunity and retinitis pigmentosa. Semin Ophthalmol. 1987;2(2):81\u20138.","journal-title":"Semin Ophthalmol"},{"issue":"3","key":"2528_CR21","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.neuron.2019.02.015","volume":"102","author":"M Telias","year":"2019","unstructured":"Telias M, Denlinger B, Helft Z, Thornton C, Beckwith-Cohen B, Kramer RH. Retinoic acid induces hyperactivity, and blocking its receptor unmasks light responses and augments vision in retinal degeneration. Neuron. 2019;102(3):574-86.e5.","journal-title":"Neuron"},{"issue":"2","key":"2528_CR22","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1189\/jlb.1102574","volume":"74","author":"JW Streilein","year":"2003","unstructured":"Streilein JW. Ocular immune privilege: the eye takes a dim but practical view of immunity and inflammation. J Leukoc Biol. 2003;74(2):179\u201385.","journal-title":"J Leukoc Biol"},{"issue":"1\u20132","key":"2528_CR23","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jneuroim.2012.10.007","volume":"254","author":"M Kyger","year":"2013","unstructured":"Kyger M, Worley A, Adamus G. Autoimmune responses against photoreceptor antigens during retinal degeneration and their role in macrophage recruitment into retinas of RCS rats. J Neuroimmunol. 2013;254(1\u20132):91\u2013100.","journal-title":"J Neuroimmunol"},{"issue":"3","key":"2528_CR24","doi-asserted-by":"publisher","first-page":"199","DOI":"10.3109\/13816818409006122","volume":"4","author":"PA Garcia-Calderon","year":"1984","unstructured":"Garcia-Calderon PA, Engel P, Cols N, Heredia Garcia CD. Immune complexes in retinitis pigmentosa. Ophthalmic Paediatr Genet. 1984;4(3):199\u2013202.","journal-title":"Ophthalmic Paediatr Genet"},{"issue":"11","key":"2528_CR25","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1001\/archopht.118.11.1525","volume":"118","author":"JR Heckenlively","year":"2000","unstructured":"Heckenlively JR, Fawzi AA, Oversier J, Jordan BL, Aptsiauri N. Autoimmune retinopathy: patients with antirecoverin immunoreactivity and panretinal degeneration. Arch Ophthalmol. 2000;118(11):1525\u201333.","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"2528_CR26","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/0008-8749(89)90375-4","volume":"118","author":"N Shinomiya","year":"1989","unstructured":"Shinomiya N, Kuratsuji T, Yata J. The role of T cells in immunoglobulin class switching of specific antibody production system in vitro in humans. Cell Immunol. 1989;118(2):239\u201349.","journal-title":"Cell Immunol"},{"key":"2528_CR27","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.3389\/fimmu.2018.02304","volume":"9","author":"I Gery","year":"2018","unstructured":"Gery I, Caspi RR. Tolerance induction in relation to the eye. Front Immunol. 2018;9:2304.","journal-title":"Front Immunol"},{"key":"2528_CR28","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/s12974-014-0205-4","volume":"11","author":"SW McPherson","year":"2014","unstructured":"McPherson SW, Heuss ND, Pierson MJ, Gregerson DS. Retinal antigen-specific regulatory T cells protect against spontaneous and induced autoimmunity and require local dendritic cells. J Neuroinflamm. 2014;11:205.","journal-title":"J Neuroinflamm"},{"issue":"4","key":"2528_CR29","first-page":"449","volume":"6","author":"A Mishra","year":"2017","unstructured":"Mishra A, Das B, Nath M, Iyer S, Kesarwani A, Bhattacharjee J, et al. A novel immunodeficient NOD.SCID-rd1 mouse model of retinitis pigmentosa to investigate potential therapeutics and pathogenesis of retinal degeneration. Biol Open. 2017;6(4):449\u201362.","journal-title":"Biol Open"},{"key":"2528_CR30","first-page":"2579","volume":"19","author":"J Han","year":"2013","unstructured":"Han J, Dinculescu A, Dai X, Du W, Smith WC, Pang J. Review: the history and role of naturally occurring mouse models with Pde6b mutations. Mol Vis. 2013;19:2579\u201389.","journal-title":"Mol Vis"},{"issue":"4","key":"2528_CR31","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1136\/bjo.2006.101576","volume":"91","author":"R Rajendram","year":"2007","unstructured":"Rajendram R, Saraswathy S, Rao NA. Photoreceptor mitochondrial oxidative stress in early experimental autoimmune uveoretinitis. Br J Ophthalmol. 2007;91(4):531\u20137.","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"2528_CR32","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1128\/MMBR.05015-11","volume":"76","author":"JR Tisoncik","year":"2012","unstructured":"Tisoncik JR, Korth MJ, Simmons CP, Farrar J, Martin TR, Katze MG. Into the eye of the cytokine storm. Microbiol Mol Biol Rev. 2012;76(1):16\u201332.","journal-title":"Microbiol Mol Biol Rev"},{"issue":"5","key":"2528_CR33","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1167\/iovs.02-0807","volume":"44","author":"S Ishida","year":"2003","unstructured":"Ishida S, Usui T, Yamashiro K, Kaji Y, Ahmed E, Carrasquillo KG, et al. VEGF164 is proinflammatory in the diabetic retina. Invest Ophthalmol Vis Sci. 2003;44(5):2155\u201362.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"2528_CR34","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S0166-2236(99)01533-7","volume":"23","author":"HD Venters","year":"2000","unstructured":"Venters HD, Dantzer R, Kelley KW. A new concept in neurodegeneration: TNFalpha is a silencer of survival signals. Trends Neurosci. 2000;23(4):175\u201380.","journal-title":"Trends Neurosci"},{"issue":"9","key":"2528_CR35","doi-asserted-by":"publisher","first-page":"6154","DOI":"10.1167\/iovs.10-6943","volume":"52","author":"X Jiang","year":"2011","unstructured":"Jiang X, McClellan SA, Barrett RP, Berger EA, Zhang Y, Hazlett LD. VIP and growth factors in the infected cornea. Invest Ophthalmol Vis Sci. 2011;52(9):6154\u201361.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2528_CR36","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1111\/j.1749-6632.2000.tb05396.x","volume":"917","author":"JW Streilein","year":"2000","unstructured":"Streilein JW, Okamoto S, Sano Y, Taylor AW. Neural control of ocular immune privilege. Ann N Y Acad Sci. 2000;917:297\u2013306.","journal-title":"Ann N Y Acad Sci"},{"key":"2528_CR37","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1002\/JLB.3MIR0817-337R","volume":"103","author":"AW Taylor","year":"2018","unstructured":"Taylor AW, Ng TF. Negative regulators that mediate ocular immune privilege. J Leukoc Biol. 2018;103:1179\u201387.","journal-title":"J Leukoc Biol."},{"issue":"Suppl 6","key":"2528_CR38","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.5301\/EJO.2010.6049","volume":"21","author":"J Cunha-Vaz","year":"2011","unstructured":"Cunha-Vaz J, Bernardes R, Lobo C. Blood-retinal barrier. Eur J Ophthalmol. 2011;21(Suppl 6):S3-9.","journal-title":"Eur J Ophthalmol"},{"issue":"6","key":"2528_CR39","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.preteyeres.2008.09.003","volume":"27","author":"C Kaur","year":"2008","unstructured":"Kaur C, Foulds WS, Ling EA. Blood-retinal barrier in hypoxic ischaemic conditions: basic concepts, clinical features and management. Prog Retin Eye Res. 2008;27(6):622\u201347.","journal-title":"Prog Retin Eye Res"},{"issue":"10","key":"2528_CR40","doi-asserted-by":"publisher","first-page":"2637","DOI":"10.2337\/db09-1421","volume":"59","author":"EC Leal","year":"2010","unstructured":"Leal EC, Martins J, Voabil P, Liberal J, Chiavaroli C, Bauer J, et al. Calcium dobesilate inhibits the alterations in tight junction proteins and leukocyte adhesion to retinal endothelial cells induced by diabetes. Diabetes. 2010;59(10):2637\u201345.","journal-title":"Diabetes"},{"issue":"9","key":"2528_CR41","doi-asserted-by":"publisher","first-page":"2380","DOI":"10.2337\/db06-1694","volume":"56","author":"D Navaratna","year":"2007","unstructured":"Navaratna D, McGuire PG, Menicucci G, Das A. Proteolytic degradation of VE-cadherin alters the blood-retinal barrier in diabetes. Diabetes. 2007;56(9):2380\u20137.","journal-title":"Diabetes"},{"issue":"12","key":"2528_CR42","doi-asserted-by":"publisher","first-page":"e15730","DOI":"10.1371\/journal.pone.0015730","volume":"5","author":"A Georgiadis","year":"2010","unstructured":"Georgiadis A, Tschernutter M, Bainbridge JW, Balaggan KS, Mowat F, West EL, et al. The tight junction associated signalling proteins ZO-1 and ZONAB regulate retinal pigment epithelium homeostasis in mice. PLoS ONE. 2010;5(12):e15730.","journal-title":"PLoS ONE"},{"issue":"11","key":"2528_CR43","doi-asserted-by":"publisher","first-page":"2872","DOI":"10.2337\/db09-1606","volume":"59","author":"CA Aveleira","year":"2010","unstructured":"Aveleira CA, Lin CM, Abcouwer SF, Ambrosio AF, Antonetti DA. TNF-alpha signals through PKCzeta\/NF-kappaB to alter the tight junction complex and increase retinal endothelial cell permeability. Diabetes. 2010;59(11):2872\u201382.","journal-title":"Diabetes"},{"issue":"3","key":"2528_CR44","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.exer.2006.01.032","volume":"83","author":"M Campbell","year":"2006","unstructured":"Campbell M, Humphries M, Kennan A, Kenna P, Humphries P, Brankin B. Aberrant retinal tight junction and adherens junction protein expression in an animal model of autosomal dominant Retinitis pigmentosa: the Rho(\u2212\/\u2212) mouse. Exp Eye Res. 2006;83(3):484\u201392.","journal-title":"Exp Eye Res"},{"issue":"1","key":"2528_CR45","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s00418-008-0424-9","volume":"130","author":"C Forster","year":"2008","unstructured":"Forster C. Tight junctions and the modulation of barrier function in disease. Histochem Cell Biol. 2008;130(1):55\u201370.","journal-title":"Histochem Cell Biol"},{"issue":"9","key":"2528_CR46","first-page":"4508","volume":"60","author":"R Gattegna","year":"2019","unstructured":"Gattegna R, Bleicher I, Iannaccone A. Emerging Phenotypic Characteristics and Identification of Novel Mutations in Autosomal Recessive Retinitis Pigmentosa (ARRP) Associated with the EYS Gene. Investig Ophthalmol Visu Sci. 2019;60(9):4508.","journal-title":"Investig Ophthalmol Visu Sci"},{"issue":"1","key":"2528_CR47","doi-asserted-by":"publisher","first-page":"4638","DOI":"10.1038\/s41598-017-03493-3","volume":"7","author":"K Lueck","year":"2017","unstructured":"Lueck K, Carr AF, Stampoulis D, Gerke V, Rescher U, Greenwood J, et al. Regulation of retinal pigment epithelial cell phenotype by Annexin A8. Sci Rep. 2017;7(1):4638.","journal-title":"Sci Rep"},{"issue":"1\u20132","key":"2528_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0165-5728(03)00248-0","volume":"144","author":"D Sun","year":"2003","unstructured":"Sun D. Retinal pigment epithelial cells activate uveitogenic T cells when they express high levels of MHC class II molecules, but inhibit T cell activation when they express restricted levels. J Neuroimmunol. 2003;144(1\u20132):1\u20138.","journal-title":"J Neuroimmunol"},{"issue":"2","key":"2528_CR49","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1586\/1744666X.5.2.137","volume":"5","author":"JY Niederkorn","year":"2009","unstructured":"Niederkorn JY. Role of NKT cells in anterior chamber-associated immune deviation. Expert Rev Clin Immunol. 2009;5(2):137\u201344.","journal-title":"Expert Rev Clin Immunol"},{"issue":"5","key":"2528_CR50","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1096\/fj.12-215715","volume":"28","author":"K Noda","year":"2014","unstructured":"Noda K, Nakao S, Zandi S, Sun D, Hayes KC, Hafezi-Moghadam A. Retinopathy in a novel model of metabolic syndrome and type 2 diabetes: new insight on the inflammatory paradigm. FASEB J. 2014;28(5):2038\u201346.","journal-title":"FASEB J"},{"issue":"6","key":"2528_CR51","doi-asserted-by":"publisher","first-page":"3157","DOI":"10.1167\/iovs.09-4390","volume":"51","author":"D Salom","year":"2010","unstructured":"Salom D, Diaz-Llopis M, Quijada A, Garc\u00eda-Delpech S, Udaondo P, Romero FJ, et al. Aqueous humor levels of hepatocyte growth factor in retinitis pigmentosa. Invest Ophthalmol Vis Sci. 2010;51(6):3157\u201361.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"2528_CR52","first-page":"743","volume":"19","author":"CJ Brinkman","year":"1980","unstructured":"Brinkman CJ, Pinckers AJ, Broekhuyse RM. Immune reactivity to different retinal antigens in patients suffering from retinitis pigmentosa. Invest Ophthalmol Vis Sci. 1980;19(7):743\u201350.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"2528_CR53","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1006\/exer.1996.0118","volume":"63","author":"VM Elner","year":"1996","unstructured":"Elner VM, Elner SG, Standiford TJ, Lukacs NW, Strieter RM, Kunkel SL. Interleukin-7 (IL-7) induces retinal pigment epithelial cell MCP-1 and IL-8. Exp Eye Res. 1996;63(3):297\u2013303.","journal-title":"Exp Eye Res"},{"key":"2528_CR54","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.3389\/fimmu.2018.02304","volume":"9","author":"I Gery","year":"2018","unstructured":"Gery I, Caspi RR. Tolerance induction in relation to the eye. Front Immunol. 2018;9:2304.","journal-title":"Front. Immunol."},{"key":"2528_CR55","doi-asserted-by":"publisher","first-page":"1679197","DOI":"10.1155\/2018\/1679197","volume":"2018","author":"H Keino","year":"2018","unstructured":"Keino H, Horie S, Sugita S. Immune Privilege and Eye-Derived T-Regulatory Cells. J Immunol Res. 2018;2018:1679197.","journal-title":"J Immunol Res"},{"issue":"11","key":"2528_CR56","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1038\/nri1224","volume":"3","author":"JW Streilein","year":"2003","unstructured":"Streilein JW. Ocular immune privilege: therapeutic opportunities from an experiment of nature. Nat Rev Immunol. 2003;3(11):879\u201389.","journal-title":"Nat Rev Immunol"},{"issue":"11","key":"2528_CR57","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/nri3073","volume":"11","author":"PJ Murray","year":"2011","unstructured":"Murray PJ, Wynn TA. Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol. 2011;11(11):723\u201337.","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"2528_CR58","doi-asserted-by":"publisher","first-page":"e1000412","DOI":"10.1371\/journal.pbio.1000412","volume":"8","author":"C Kilkenny","year":"2010","unstructured":"Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG. Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol. 2010;8(6):e1000412.","journal-title":"PLoS Biol"},{"key":"2528_CR59","first-page":"811","volume":"21","author":"M van Wyk","year":"2015","unstructured":"van Wyk M, Schneider S, Kleinlogel S. Variable phenotypic expressivity in inbred retinal degeneration mouse lines: a comparative study of C3H\/HeOu and FVB\/N rd1 mice. Mol Vis. 2015;21:811\u201327.","journal-title":"Mol Vis"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-022-02528-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-022-02528-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-022-02528-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,17]],"date-time":"2022-10-17T06:08:48Z","timestamp":1665986928000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-022-02528-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,17]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2528"],"URL":"https:\/\/doi.org\/10.1186\/s13023-022-02528-x","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,17]]},"assertion":[{"value":"11 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This investigation was approved by the Institutional Human Ethics Committee (IHEC#100\/17) of National Institute of Immunology (NII), New Delhi and the Ethic Committee, Dr Shroff\u2019s Charity Eye Hospital (dated 22 May 2017), New Delhi. The investigation on mice was approved by the Institutional Animal Ethics Committee (IAEC# 480\/18) of NII, New Delhi. All animal experiments and reporting adhere to the ARRIVE guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"378"}}